Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 1 receptor-like 1 (IL1RL1), also known as ST2, is a receptor belonging to the interleukin-1 receptor family. It exists in two main isoforms: a membrane-bound form (ST2L) that functions as a cell surface receptor for interleukin-33 (IL-33), and a soluble form (sST2) that acts as a decoy for IL-33. The IL-33/ST2 signaling pathway plays important roles in regulating immune responses, particularly in allergic inflammation and asthma, and has significant effects on cardiac tissue, where it can mediate cardioprotective effects. Soluble ST2 is a biomarker for heart failure.
sST2 acts as a decoy receptor, binding IL-33 and preventing it from interacting with membrane-bound ST2L, thus inhibiting downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 Receptor-Like 1 Protein (IL1RL1).